A re-analysis of "failed" non-invasive prenatal tests based on whole-genome sequence data revealed hundreds of rare autosomal trisomies.
Natera discussed its plans to move into the whole-genome newborn screening market and provided updates on its NIPT and oncology businesses.
Natera saw total Q4 2016 revenues decline to $49.3 million, despite an increase in testing volumes.
GenePeeks will provide its Virtual Progeny Analytics approach, which includes scores that predict gene function and associated disease risk in hypothetical babies.
The firm reported $3.5 million in revenue for the three months ended Dec. 31, 2016, and $12.9 million for the full year.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.